RASTETTER WILLIAM H — SEC Form 4 filings

SEC reporting owner CIK 1205903. 19 Form 4 filings on record with FilingPulse; latest filed 2026-07-02.

Transaction summary — filings shown

Covers all 19 filings on record, filed 2024-05-17 to 2026-07-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
NEUROCRINE BIOSCIENCES INC (NBIX)Director73 legs · 62,250 sh · $8,128,97411
Regulus Therapeutics Inc. (RGLS)Director413
FATE THERAPEUTICS INC (FATE)Director45
Dare Bioscience, Inc. (DARE)Director44

Form 4 filings — RASTETTER WILLIAM H

FiledFormIssuerReported transactionsSource
2026-07-024Dare Bioscience, Inc. (DARE)Grant/award (A): 38,862 @ $0EDGAR
2026-06-154FATE THERAPEUTICS INC (FATE)Grant/award (A): 87,900 (derivative) @ $0EDGAR
2026-06-114Dare Bioscience, Inc. (DARE)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2026-05-294NEUROCRINE BIOSCIENCES INC (NBIX)Grant/award (A): 2,567 (derivative) @ $0EDGAR
2026-05-214NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 3,318 @ $0 · Option exercise (M): 3,318 (derivative) @ $0EDGAR
2026-05-064FATE THERAPEUTICS INC (FATE)Option exercise (M): 25,000 @ $1.69 · Option exercise (M): 25,000 (derivative) @ $0EDGAR
2025-11-064NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 18,000 @ $47.89 · Sale (S): 18,000 @ $151.82 · Option exercise (M): 18,000 (derivative) @ $0EDGAR
2025-07-104Dare Bioscience, Inc. (DARE)Grant/award (A): 4,500 (derivative) @ $0EDGAR
2025-06-274Regulus Therapeutics Inc. (RGLS)Code (U): 44,264 · Disposition to issuer (D): 57,292 · Disposition to issuer (D): 4,650 (derivative) · Disposition to issuer (D): 2,325 (derivative) · Disposition to issuer (D): 4,000 (derivative) · Disposition to issuer (D): 9,000 (derivative) · +4 moreEDGAR
2025-05-304FATE THERAPEUTICS INC (FATE)Grant/award (A): 55,000 (derivative) @ $0EDGAR
2025-05-224NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 2,869 @ $0 · Grant/award (A): 3,318 (derivative) @ $0 · Option exercise (M): 2,869 (derivative) @ $0EDGAR
2025-05-074NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 30,000 @ $42.76 · Sale (S): 30,000 @ $110.20 · Option exercise (M): 30,000 (derivative) @ $0EDGAR
2025-04-304Regulus Therapeutics Inc. (RGLS)Grant/award (A): 62,500 @ $0EDGAR
2024-08-164NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 14,250 @ $146.69EDGAR
2024-06-114FATE THERAPEUTICS INC (FATE)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2024-06-074Dare Bioscience, Inc. (DARE)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2024-05-234NEUROCRINE BIOSCIENCES INC (NBIX)Grant/award (A): 2,869 (derivative) @ $0EDGAR
2024-05-214Regulus Therapeutics Inc. (RGLS)Grant/award (A): 60,000 (derivative) @ $0EDGAR
2024-05-174Regulus Therapeutics Inc. (RGLS)Grant/award (A): 30,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1205903 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →